Find the Perfect Plan for Your Investment Journey
Latest price
52 Week Range
CN¥12.32 - CN¥23.48
Next Earnings Date
Apr 28 2025
Next Earnings Date
Apr 28 2025
Latest price
Market Cap | CN¥10.68B |
EV | CN¥8.34B |
Shares Outstanding | 733.37M |
Beta | 0.91 |
Analyst Rating | OUTPERFORM |
Analyst Target Price | CN¥17.27 |
P/E 2025E | 34.42x |
P/Revenue 2025E | 5.21x |
Revenue | 10.00% |
EPS | -49.40% |
Operating Cash Flow | -20.90% |
Free Cash Flow | -46.10% |
Revenue | 9.00% |
EPS | 100.00% |
Operating Cash Flow | 8.50% |
Free Cash Flow | 70.80% |
Gross Margin 2025E | 29.91% |
Net Profit Margin 2025E | 16.37% |
ROE 2025E | 4.02% |
ROCE 2024 | 0.91% |
DPS 2025E | CN¥0.15 |
Payout Ratio 2025E | 33.33% |
Div. Yield 2025E | 0.98% |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
Joinn Laboratories(China)Co.,Ltd.
603127
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Gao, Dapeng
Employees
2,510
Website
www.joinn-lab.comIPO Date
2017-08-25
Headquarters
A5 Rongjing East Street, Beijing Eco-Techno Development Area, Beijing 100176, China
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved